Welcome to our dedicated page for Pennant Group SEC filings (Ticker: PNTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering where to locate Medicare reimbursement details, occupancy percentages or executive stock sales hidden inside Pennant Group disclosures? Those data points are scattered across multi-section 10-Ks, dense 10-Qs and late-night 8-Ks. This page brings every Pennant Group SEC filing into one place and lets Stock Titan’s AI do the heavy lifting.
Skip the 200-page search. Our platform instantly converts raw documents into clear takeaways, turning “Pennant Group insider trading Form 4 transactions” and “Pennant Group quarterly earnings report 10-Q filing” into plain-English summaries. Want real-time alerts? New filings hit your dashboard seconds after EDGAR posts them—so you’ll see Pennant Group Form 4 insider transactions real-time before the market reacts.
- 10-K & 10-Q—Track segment EBITDA, payor mix and occupancy metrics with Pennant Group annual report 10-K simplified and Pennant Group earnings report filing analysis.
- 8-K—Material event updates such as hospice acquisitions or leadership changes, fully tagged for Pennant Group 8-K material events explained.
- Form 4—Follow Pennant Group executive stock transactions Form 4 and spot emerging patterns.
- DEF 14A—Review Pennant Group proxy statement executive compensation without wading through boilerplate.
Each filing comes with an AI-powered synopsis that highlights revenue drivers, regulatory risks and key footnotes—understanding Pennant Group SEC documents with AI becomes effortless. Real-time updates, historical archives and side-by-side comparisons give you the context you need to evaluate census trends or reimbursement rate shifts before making a decision.
Whether you’re monitoring cost-of-care pressures, analysing hospice margins or checking Pennant Group SEC filings explained simply, Stock Titan turns complex disclosure into actionable insight—no forensic accounting required.
Pennant Group, Inc. Schedule 13G/A reports that FMR LLC and Abigail P. Johnson together beneficially hold 1,071,334.13 shares of Pennant Group common stock, representing 3.1% of the class. The filing shows FMR LLC has sole voting power over 1,068,803 shares and sole dispositive power over 1,071,334.13 shares; Abigail P. Johnson reports sole dispositive power for the same aggregate amount and no voting power. The filing is dated as an event on 08/29/2025 and signed on 09/05/2025. The Schedule references Exhibit 99 for a 13d-1(k)(1) agreement and incorporates powers of attorney by reference.
8 Knots affiliates disclosed a 7.70% stake in The Pennant Group, Inc. (PNTG). The filing shows 8 Knots Management, LLC and Scott Green each report beneficial ownership of 2,652,806 shares, representing 7.70% of the 34,468,981 shares outstanding used for the calculation. Holdings are held across funds and separately managed accounts: 8 Knots Fund (1,403,748 shares, 4.07%), 8 Knots Fund II (117,516 shares, 0.34%), and aggregate SMA holdings of 887,959 shares. 8 Knots Management is the adviser to the funds and SMAs and disclaims beneficial ownership of certain sub-advised and SMA positions where agreements are terminable. The filing includes a joint filing agreement signed August 7, 2025.
FAQ
What is the current stock price of Pennant Group (PNTG)?
What is the market cap of Pennant Group (PNTG)?
